Douglas F. Kling

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Louise Kooij by Power of Attorney from Douglas F. Kling
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas F. Kling:

Company Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Operating Officer Ordinary Shares 44,000 $928,400 $21.10 16 Jul 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Operating Officer Option (right to buy) 162,702 16 Jul 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Operating Officer Restricted Stock Unit 0 26 Mar 2025 Direct

Insider Reports Filed by Douglas F. Kling

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NAMS NewAmsterdam Pharma Co N.V. 15 Jul 2025 7 -$1,021,784 4 Chief Operating Officer 17 Jul 2025, 17:19
NAMS NewAmsterdam Pharma Co N.V. 16 Jun 2025 6 -$909,432 4 Chief Operating Officer 18 Jun 2025, 16:50
NAMS NewAmsterdam Pharma Co N.V. 15 May 2025 3 +$1,000,000 4 Chief Operating Officer 19 May 2025, 16:44
NAMS NewAmsterdam Pharma Co N.V. 15 Apr 2025 4 +$1,000,000 4 Chief Operating Officer 17 Apr 2025, 17:41
NAMS NewAmsterdam Pharma Co N.V. 26 Mar 2025 4 $0 4 Chief Operating Officer 28 Mar 2025, 17:18
NAMS NewAmsterdam Pharma Co N.V. 17 Mar 2025 5 +$118,880 4 Chief Operating Officer 19 Mar 2025, 17:29
NAMS NewAmsterdam Pharma Co N.V. 18 Feb 2025 6 $0 4 Chief Operating Officer 20 Feb 2025, 17:24
NAMS NewAmsterdam Pharma Co N.V. 29 Jan 2025 7 $0 4 Chief Operating Officer 31 Jan 2025, 17:00
NAMS NewAmsterdam Pharma Co N.V. 27 Jan 2025 8 $0 4 Chief Operating Officer 29 Jan 2025, 17:16
NAMS NewAmsterdam Pharma Co N.V. 07 Jan 2025 1 $0 4 Chief Operating Officer 07 Jan 2025, 17:10
NAMS NewAmsterdam Pharma Co N.V. 02 Jan 2025 1 $0 4 Chief Operating Officer 06 Jan 2025, 17:57
NAMS NewAmsterdam Pharma Co N.V. 01 Jan 2024 1 $0 4 Chief Operating Officer 03 Jan 2024, 17:21
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3 Chief Operating Officer 29 Dec 2023, 16:30